Reglan (generic: metoclopramide), has been linked to serious adverse effects such as Tardive Dyskinesia and Neuroleptic Malignant Syndrome.
Approved by the FDA in 2004, Reglan is used to treat nausea, vomiting, and heartburn caused by gastric reflux. Although the label mentions tardive dyskinesia, it indicated that the occurrence is rare. Unfortunately, 27-29 percent of long-term Reglan users have developed Tardive Dyskinesia.
FDA Reglan Warning: On February 25, 2009, The U.S. Food & Drug Administration (FDA) required the manufacturers of metoclopramide-containing drugs (Reglan) to add a “Black Box” warning to the products warning of an increased risk of the development of Tardive Dyskinesia.
UPDATE: 650 Lawsuits Involving Generic Reglan Allowed to Proceed
November 13, 2014 — An appeals court in New Jersey has ruled that hundreds of failure-to-warn lawsuits involving generic Reglan (metoclopramide) are not preempted by federal law. Click here to read more.
What is the problem with Reglan?
Reglan is a common treatment for those suffering from nausea, vomiting, and heartburn from gastric reflux. The FDA approved Reglan for a short-term use of 4-12 weeks. Approximately 1/3 of Reglan users have been prescribed it for more than 12 weeks. This extended usage put the patient at greater risk of Tardive Dyskinesia.
Tardive Dyskinesia is a neurological syndrome caused by the long-term use of neuroleptic drug. It is characterized by constant movements of the mouth, tongue, jaw, and cheeks. Tardive Dyskinesia symptoms can range from mild to severe, based on the frequency and intensity of the movements.
The Devastating Side Effects of Reglan – Tardive Dyskinesia Victims Have Rights!
Tardive Dyskinesia (TD) is a devastating and sometimes lifelong syndrome for those diagnosed. It affects its victims physically, mentally, socially, emotionally, and vocationally.
One of the worst aspects of Tardive Dyskinesia for many victims is the fact that they should have never developed the syndrome in the first place.